Header

UZH-Logo

Maintenance Infos

Treatment of travellers' diarrhoea with fleroxacin: a case study


Steffen, Robert; Jori, J; DuPont, H L; Mathewson, J J; Stürchler, D (1993). Treatment of travellers' diarrhoea with fleroxacin: a case study. Journal of Antimicrobial Chemotherapy, 31(5):767-776.

Abstract

A double-blind, randomized, placebo-controlled trial was conducted to evaluate the efficacy and safety of fleroxacin for one or two days as treatment for patients with travellers' diarrhoea. A total of 195 patients who were suffering with acute diarrhoea of less than six days' duration were enrolled. One hundred and fifty-one patients, of whom 49 received placebo, 54 received fleroxacin 400 mg for one day and 48 received fleroxacin 400 mg for two days, were included in the analysis of efficacy. The results showed that fleroxacin was significantly superior to placebo, but that there was no significant difference in terms of efficacy between the one- and two-day regimens. Adverse events, particularly minor neuropsychiatric disturbances such as headache and insomnia, were significantly more common amongst patients receiving active treatment. In conclusion, a single dose of fleroxacin 400 mg could be recommended as self-treatment for visitors to high-risk countries who develop travellers' diarrhoea.

Abstract

A double-blind, randomized, placebo-controlled trial was conducted to evaluate the efficacy and safety of fleroxacin for one or two days as treatment for patients with travellers' diarrhoea. A total of 195 patients who were suffering with acute diarrhoea of less than six days' duration were enrolled. One hundred and fifty-one patients, of whom 49 received placebo, 54 received fleroxacin 400 mg for one day and 48 received fleroxacin 400 mg for two days, were included in the analysis of efficacy. The results showed that fleroxacin was significantly superior to placebo, but that there was no significant difference in terms of efficacy between the one- and two-day regimens. Adverse events, particularly minor neuropsychiatric disturbances such as headache and insomnia, were significantly more common amongst patients receiving active treatment. In conclusion, a single dose of fleroxacin 400 mg could be recommended as self-treatment for visitors to high-risk countries who develop travellers' diarrhoea.

Statistics

Citations

Dimensions.ai Metrics
14 citations in Web of Science®
19 citations in Scopus®
12 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

1 download since deposited on 03 Jul 2015
1 download since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Epidemiology, Biostatistics and Prevention Institute (EBPI)
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:May 1993
Deposited On:03 Jul 2015 13:51
Last Modified:24 Jul 2018 17:04
Publisher:Oxford University Press
ISSN:0305-7453
OA Status:Green
Publisher DOI:https://doi.org/10.1093/jac/31.5.767
PubMed ID:8335504

Download

Download PDF  'Treatment of travellers' diarrhoea with fleroxacin: a case study'.
Preview
Content: Published Version
Language: English
Filetype: PDF (Nationallizenz 142-005)
Size: 526kB
View at publisher